News
DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...
This decentralized approach aims to make treatment much easier to access, especially for those facing travel difficulties, ...
HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers successfully suppressed the virus in mice and discovered a way to kill infected cells ...
The FDA has approved a twice-yearly injection for HIV prevention following a groundbreaking clinical trial. Years before the ...
Yeztugo, a twice yearly injection, offers a promising advancement in HIV prevention, but high costs and insurance uncertainties may limit its accessibility.
The National Agency for the Control of AIDS (NACA) has called on the government to urgently shift toward country-led ...
The vast majority of positive tests have come from people in Bangor who have either been homeless, injection drug users, or ...
A new national study from Columbia University Mailman School of Public Health, with colleagues at the University of Miami ...
Experts welcome the news that PEPFAR funding remains intact, but few details about how and where services will be ...
THERE is no cure for HIV-AIDS in PNG as claimed by a popular social media content producer, says the National Department of ...
HIV and TB remain two of our biggest public health threats in Eastern Highlands Province, says Health Promotion Officer, HEO ...
Similarly, Gilead has provided nearly $35.8 million in total philanthropic support for Black women-led and/or Black ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results